                         SEQUENCE LISTING

<110>  The United States of America, as represented by the 
       Secretary, Department of Health and Human Services
       Green, Jeffrey E
       Kim, Hark K
 
<120>  GENE EXPRESSION PREDICTORS OF CHEMORESISTANCE

<130>  4239-81660-03

<150>  US  61/195,123
<151>  2008-10-03

<150>  US 61/178,392
<151>  2009-05-14

<160>  7     

<170>  PatentIn version 3.5

<210>  1
<211>  18
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer EGFR Forward

<400>  1
tgcgtctctt gccggaat                                                     18


<210>  2
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer EGFR Reverse

<400>  2
ggctcaccct ccagaagctt                                                   20


<210>  3
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide TaqMan probe

<400>  3
acgcattccc tgcctcggct g                                                 21


<210>  4
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer FGFR-2 Forward

<400>  4
caatgtgacg gagatggatg                                                   20


<210>  5
<211>  20
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer FGFR-2 Reverse

<400>  5
gatgactgtc accaccatgc                                                   20


<210>  6
<211>  21
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer MYC Forward

<400>  6
caaacctcct cacagcccac t                                                 21


<210>  7
<211>  22
<212>  DNA
<213>  Artificial Sequence

<220>
<223>  Synthetic oligonucleotide primer MYC Reverse

<400>  7
ttcgcctctt gacattctcc tc                                                22


